Breaking News Instant updates and real-time market news.
2019-11-22 07:25:00
RDHL
RedHill Biopharma
$5.70
-0.21 (-3.55%)
07:25
11/22/19
11/22
07:25
11/22/19
07:25
RedHill Biopharma to host investor & analyst day
Investor & Analyst Day to be held in New York on November 22 at 8 am. Webcast Link
22
Nov
RDHLRedHill Biopharma
$5.70
-0.21 (-3.55%)
02/27/19
HCWC
02/27/19 NO CHANGETarget $16 HCWC Buy
RedHill Biopharma price target lowered to $16 from $36 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered his price target for RedHill Biopharma to $16 saying reliance on a potential partnership could reduce RHB-104's economic value. Based on management comments, the analyst believes RedHill will likely wait for a partnership before moving the RHB-104 program forward. However, Ramakanth still expects Talicia to be approved with a potential commercial launch in the U.S. by Q4. The analyst reiterates a Buy rating on the shares.
03/12/19
WBBS
03/12/19 UPGRADEWBBS Buy
RedHill Biopharma upgraded to Buy from Hold at WBB Securities
03/12/19
03/12/19 UPGRADE
Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. American Electric (AEP) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Turnure saying the company has filled out $1.4B of non-utility renewables investment and entered into an Oklahoma settlement that "bodes well for lag catch up" over the last two months. 2. Lloyds Banking (LYG) upgraded to Neutral from Sell at Goldman Sachs. 3. RedHill Biopharma (RDHL) upgraded to Buy from Hold at WBB Securities. 4. Eaton (ETN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Jeffrey Hammond saying he believes the stock has traded at an "unwarranted discount" to peers. 5. Ranger Energy (RNGR) upgraded to Overweight from Equal Weight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/19
WBBS
07/12/19 UPGRADEWBBS Strong Buy
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities